• Research & Development

Neuronano’s technology for Deep Brain Stimulation (DBS) is a novel invention in several important aspects compared to today’s treatments. The technology will facilitate improved safety for patients at every step, while providing a more specific and effective treatment. This will result in fewer side effects and a better life for patients overall.


The DBS treatment used today is based on technology primarily developed in the 1980s and 90s. This does not preclude the treatment from helping people with Parkinson’s disease, but the time is ripe for a more biocompatible and precise technology. A technology which, using greater precision than today, can stimulate exactly the nerve cells in the brain that produce the best result. Together, fewer side effects and better effectiveness will result in a considerably higher quality of life.


DBS is a treatment in which electrodes are surgically implanted in the brain. Using small electrical impulses, the electrodes stimulate areas of the brain which respond by alleviating symptoms in people with, for example, Parkinson’s disease. One of the drawbacks of today’s technology is that the relatively large electrodes cause damage to the area they are intended to treat. The electrodes are often encapsulated and the nerve cells nearest to them may be dead, which in turn necessitates a higher electrical current in order to successfully stimulate the living nerve cells further away. This increases the risk of side effects during treatment.

Innovative technology

Neuronano’s innovative technology enables the stimulation of nerve cells in the brain with a brand new kind of electrode that is both thinner and more flexible than those used today. These electrodes can smoothly adapt to the brain’s movements without irritating or damaging tissue, which enables stable contact with the nerve cells located right next to the electrodes. The short distance to living nerve cells permits a lower electrical current for their activation and thus has the potential to produce fewer side effects, if any. Thus a more specific treatment is assured, which will translate into improved efficacy, fewer side effects and improved quality of life for Parkinson’s patients.


Because patient safety is Neuronano’s primary focus, every detail of our technology is carefully considered. We eliminate risks by only using tissue-friendly materials which meet all applicable regulatory requirements and innovative constructions which permit a gentle neurosurgical implantation technique.

Contact us to find out more

Contact us to know more about our research and development

contact us